FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Imipramine Hydrochloride Tablet
Status: Discontinuation
»Therapeutic Categories: Psychiatry

Expand all

Par Pharmaceutical, Inc. (Revised 09/15/2023)

Company Contact Information:
800-828-9393

Presentation	Posting Date	Related Information
Imipramine Hydrochloride, Tablet, 50 mg (NDC 49884-056-01)	09/14/2023	ANDA ownership transferred
Imipramine Hydrochloride, Tablet, 50 mg (NDC 49884-056-10)	09/14/2023	ANDA ownership transferred
Imipramine Hydrochloride, Tablet, 25 mg (NDC 49884-055-10)	09/14/2023	ANDA ownership transferred
Imipramine Hydrochloride, Tablet, 25 mg (NDC 49884-055-01)	09/14/2023	ANDA ownership transferred
Imipramine Hydrochloride, Tablet, 10 mg (NDC 49884-054-01)	09/14/2023	ANDA ownership transferred
Imipramine Hydrochloride, Tablet, 10 mg (NDC 49884-054-10)	09/14/2023	ANDA ownership transferred